Li J. Zuo

Key Laboratory Of Renal Disease
Beijing, 100034, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 163 publications

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.

Journal: JAMA

Published: June 04, 2026

Roxadustat Inhibits Osteoclast Differentiation and Function by Disrupting Cell Cycle Exit.

Roxadustat Inhibits Osteoclast Differentiation and Function by Disrupting Cell Cycle Exit.

Journal: International journal of molecular sciences

Published: May 14, 2026

Performance-based classification of dialyzers: integrating YKL-40 for advanced middle-molecule clearance - A Chinese expert consensus.

Performance-based classification of dialyzers: integrating YKL-40 for advanced middle-molecule clearance - A Chinese expert consensus.

Journal: Renal failure

Published: May 05, 2026

Fibrillarin-mediated 2'-O-methylation serves as a translation brake on uncapped enterovirus RNA.

Fibrillarin-mediated 2'-O-methylation serves as a translation brake on uncapped enterovirus RNA.

Journal: PLoS pathogens

Published: February 26, 2026

Amelioration of CKD-induced cardiomyocyte hypertrophy by pegmolesatide: involvement of JAK2/STAT3 inhibition and mitochondrial protection.

Amelioration of CKD-induced cardiomyocyte hypertrophy by pegmolesatide: involvement of JAK2/STAT3 inhibition and mitochondrial protection.

Journal: Frontiers in pharmacology

Published: February 07, 2026

Effects of rhEPO-Fc on chronic renal anemia in Chinese patients undergoing maintenance hemodialysis: a multicenter, randomized, open-label, and phase 3 study.

Effects of rhEPO-Fc on chronic renal anemia in Chinese patients undergoing maintenance hemodialysis: a multicenter, randomized, open-label, and phase 3 study.

Journal: Renal failure

Published: January 02, 2026

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.

Journal: American journal of nephrology

Published: December 09, 2025

Safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate for hyperkalemia management in China: actualize study.

Safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate for hyperkalemia management in China: actualize study.

Journal: Frontiers in pharmacology

Published: November 12, 2025

Difelikefalin in Chinese patients with chronic kidney disease-associated pruritus.

Difelikefalin in Chinese patients with chronic kidney disease-associated pruritus.

Journal: Clinical kidney journal

Published: November 11, 2025

China Kidney Disease Network (CK-NET) 2017-2018 Annual Data Report.

China Kidney Disease Network (CK-NET) 2017-2018 Annual Data Report.

Journal: Kidney international supplements

Published: September 15, 2025

Decade-Long Trends in Chronic Kidney Disease-Mineral and Bone Disorder Target Achievement and Mortality Associations among Chinese Hemodialysis Patients: Insights from the China DOPPS Study.

Decade-Long Trends in Chronic Kidney Disease-Mineral and Bone Disorder Target Achievement and Mortality Associations among Chinese Hemodialysis Patients: Insights from the China DOPPS Study.

Journal: Kidney diseases (Basel, Switzerland)

Published: September 06, 2025

Randomized Double-Blind Trial of WS016 in Chinese Patients With Hyperkalemia.

Randomized Double-Blind Trial of WS016 in Chinese Patients With Hyperkalemia.

Journal: Kidney international reports

Published: August 06, 2025

Showing 1-12 of 163

Last Updated: 09/26/2026